Results 271 to 280 of about 119,702 (338)
Glymphatic system dysfunction and risk of clinical milestones in patients with Parkinson disease. [PDF]
Zhou C+17 more
europepmc +1 more source
Anxiety Symptoms and Disease Severity in Parkinson Disease. [PDF]
Whitmarsh A, Protea S, Gibson JS.
europepmc +1 more source
Clinical tools that can aid in the diagnostic differentiation of juvenile dermatomyositis from muscular dystrophy.
Jacqueline A. Madison+9 more
wiley +1 more source
Attitudes and beliefs towards medication burden and deprescribing in Parkinson disease. [PDF]
Pham Nguyen TP+3 more
europepmc +1 more source
Objective The aim of this study was to determine whether pollutants such as fire smoke–related particulate matter <2.5 μm (PM2.5) are associated with incident rheumatoid arthritis (RA) and RA‐associated interstitial lung disease (RA‐ILD). Methods This patient–control study used Veterans Affairs (VA) data from October 1, 2009, to December 31, 2018.
Vanessa L. Kronzer+13 more
wiley +1 more source
ABSTRACT Postural control deviations remain largely unexplored in middle aged and older autistic adults. With the increased prevalence of neurodegenerative conditions and heightened fall risk, precise quantification of postural variability and coordination may provide valuable insights into aging associated neuromotor deviations in autistic adults ...
Hang Qu+8 more
wiley +1 more source
Reliability of Average Daily Steps Measured Through a Consumer Smartwatch in Parkinson Disease Phenotypes, Stages, and Severities: Cross-Sectional Study. [PDF]
Bianchini E+9 more
europepmc +1 more source
Cognitive and Cerebral Aging Research in Autism: A Systematic Review on an Emerging Topic
ABSTRACT Aging in autism is an emerging and under‐explored area of research. This systematic review provides a comprehensive overview of studies on cognitive and both structural and functional cerebral aging in autism. A systematic search of PubMed and APA PsycInfo was conducted up to and including January 2024.
Marine Bessé+9 more
wiley +1 more source
Comparing balance using the BESTest in Alzheimer, Huntington and Parkinson disease. [PDF]
Tueth LE+3 more
europepmc +1 more source
Aims The aim of this phase 1 trial was to assess the pharmacokinetics, safety and tolerability of balcinrenone (previously AZD9977) in participants with severe renal impairment vs. those with normal renal function. Methods Participants with severe renal impairment (estimated glomerular filtration rate [eGFR] < 30 mL/min/1.73 m2) not on dialysis were ...
Chandrali S. Bhattacharya+10 more
wiley +1 more source